Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Would a finding of isolated tumor cells on SNB impact your decision to offer omission of radiation in a patient with breast cancer who is otherwise a candidate?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

ITCs raise our eyebrows, for sure, but are not technically a reason to treat. As this was not recorded in the CALGB study and the majority of patients did not have any axillary evaluation, it is quite likely a portion of patients had ITCs, and yet still did not have excessive rates of recurrence.Tha...

Would you recommend PMRT for T2N0(i+) breast cancer?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

In this situation, I do not normally offer PMRT as long as margins are negative. There are some that would consider in this scenario if triple negative but I don’t usually.

Do you recommend additional nodal boost in patients with suspicious internal mammary nodes that respond completely after neoadjuvant chemotherapy?

5
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

Our standard practice is to boost undissected regional nodes (IMC, ICV, SCV) that completely respond radiographically, an additional 10 Gy after regional nodal irradiation, and boost those that persist on imaging after chemotherapy 16 Gy. If the radiographic complete response was associated with sig...

How would you approach adjuvant RT for porocarcinoma of the face?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Medical University of South Carolina (Charleston)

The reported outcomes after surgery in the published literature are all over the place. With some saying surgery alone is adequate and others reporting that these have a high incidence of local, in-transit, and regional recurrence. I tend to treat these with Merkel cell carcinoma volumes.

Would you treat an enlarging metastasis of the brainstem/upper cervical spinal cord with SRS in the setting of widespread disease and prior WBRT?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Columbia University Irving Medical Center

From what I understand, this is a patient with extensive-stage SCLC and widespread intracranial disease (>40 brain metastases), previously treated with WBRT (presumably 30 Gy in 10 fractions?), now presenting with a symptomatic (~2–3 cm) enlarging lesion at the brainstem/upper cervical spinal cord j...

What are indications for adjuvant radiation for well differentiated non-intestinal adenocarcinoma of the nasal cavity?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

I would irradiate all except a well defined T1N0 resected en bloc with negative margins.

How would you palliate a large, symptomatic vaginal melanoma recurrence with limited small pelvic lymph node metastases?

5 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Palliation. Treat problems that are symptomatic. No expensive systemic work up. Pall RT to the pelvis if it’s symptomatic. 30 Gy/10 fractions, 25 Gy/5 fractions, or 20 Gy/2 fractions with a 1 week inter-fraction interval. Apologize for the lengthy response.

Would you omit radiation to the R0 tonsil tumor bed after TORS for p16+ tonsillar SCC when delivering adjuvant radiation to the neck due to + lymph nodes found intraoperatively?

5
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Texas MD Anderson Cancer Center

No This is a strategy being advocated particularly from centers that are strongly surgery driven. There has been at least one publication, but the data so far is with small retrospective sample sizes. There is a certain historic irony, as when postoperative radiation was initially advocated in the 1...

Do you require both biopsy of the primary in addition to nodes in your practice for HNC?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Emory University

While it is ideal to get biopsy from a putative primary and putative nodes, I do not think that it is needed. In cases with a known mucosal H+N primary and several PET avid nodes, I would almost never request biopsy and just treat those as gross disease. The more challenging situation is when you ha...

In stage 4 hilar cholangiocarcinoma, after stenting the biliary tree is there value in radiating the hilar area in addition to systemic therapy so as to maintain patency of the biliary system for a longer period of time or do you depend on the systemic therapy and the stenting alone?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

In the setting of metastatic hilar cholangiocarcinoma, biliary patency is one issue but the greater issue is colonization of the biliary tree with gut flora that leads to repeated bouts of cholangitis, and progressive biliary sclerosis that happens regardless of the use of radiation. These patients ...